| Literature DB >> 26697836 |
Xiao-Xin Sun1, Rosalie C Sears1, Mu-Shui Dai1.
Abstract
Ubiquitination plays a key and complex role in the regulation of c-Myc stability, transactivation, and oncogenic activity. c-Myc is ubiquitinated by a number of ubiquitin ligases (E3s), such as SCF(Fbw7) and SCF(Skp2). Depending on the E3s, ubiquitination can either positively or negatively regulate c-Myc levels and activity. Meanwhile, c-Myc ubiquitination can be reversed by deubiquitination. An early study showed that USP28 deubiquitinates c-Myc via interacting with Fbw7α whereas a recent study reveals that USP37 deubiquitinates c-Myc independently of Fbw7 and c-Myc phosphorylation. Consequently, both USP28 and USP37 stabilize c-Myc and enhance its activity. We recently found the nucleolar USP36 as a novel c-Myc deubiquitinase that controls the end-point of c-Myc degradation pathway in the nucleolus. Here we briefly review the current understanding of ubiquitination and deubiquitination regulation of c-Myc and further discuss the USP36-c-Myc regulatory pathway.Entities:
Keywords: USP36; c-Myc; deubiquitinating enzymes; nucleolus; ubiquitination
Mesh:
Substances:
Year: 2015 PMID: 26697836 PMCID: PMC4825782 DOI: 10.1080/15384101.2015.1093713
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534